These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18580872)

  • 41. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation, and extinction.
    Sachser RM; Crestani AP; Quillfeldt JA; Mello E Souza T; de Oliveira Alvares L
    Learn Mem; 2015 Dec; 22(12):584-8. PubMed ID: 26572648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
    Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB
    Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system.
    Perra S; Pillolla G; Luchicchi A; Pistis M
    Alcohol Clin Exp Res; 2008 Mar; 32(3):443-9. PubMed ID: 18215217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
    Sheinin A; Talani G; Davis MI; Lovinger DM
    J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates.
    Butler RK; Rea K; Lang Y; Gavin AM; Finn DP
    Pain; 2008 Dec; 140(3):491-500. PubMed ID: 19004548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CB1 Receptor Signaling Modulates Amygdalar Plasticity during Context-Cocaine Memory Reconsolidation to Promote Subsequent Cocaine Seeking.
    Higginbotham JA; Wang R; Richardson BD; Shiina H; Tan SM; Presker MA; Rossi DJ; Fuchs RA
    J Neurosci; 2021 Jan; 41(4):613-629. PubMed ID: 33257326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
    Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats.
    Robinson L; McKillop-Smith S; Ross NL; Pertwee RG; Hampson RE; Platt B; Riedel G
    Psychopharmacology (Berl); 2008 Jul; 198(4):551-63. PubMed ID: 18049812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear.
    Bisby MA; Richardson R; Baker KD
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109834. PubMed ID: 31830508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The endogenous cannabinoid system controls extinction of aversive memories.
    Marsicano G; Wotjak CT; Azad SC; Bisogno T; Rammes G; Cascio MG; Hermann H; Tang J; Hofmann C; Zieglgänsberger W; Di Marzo V; Lutz B
    Nature; 2002 Aug; 418(6897):530-4. PubMed ID: 12152079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle.
    Gutman AR; Yang Y; Ressler KJ; Davis M
    J Neurosci; 2008 Nov; 28(48):12682-90. PubMed ID: 19036961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist AM251 blocked propofol-induced anterograde amnesia.
    Ren Y; Wang J; Xu PB; Xu YJ; Miao CH
    Neurosci Lett; 2015 Jan; 584():287-91. PubMed ID: 25445359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
    Laricchiuta D; Centonze D; Petrosini L
    Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction.
    Lafenêtre P; Chaouloff F; Marsicano G
    Pharmacol Res; 2007 Nov; 56(5):367-81. PubMed ID: 17951068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous cannabinoid signaling through the CB1 receptor is essential for cerebellum-dependent discrete motor learning.
    Kishimoto Y; Kano M
    J Neurosci; 2006 Aug; 26(34):8829-37. PubMed ID: 16928872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats.
    Ford GK; Kieran S; Dolan K; Harhen B; Finn DP
    Pain; 2011 Nov; 152(11):2495-2504. PubMed ID: 21864979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment.
    Nedaei SE; Rezayof A; Pourmotabbed A; Nasehi M; Zarrindast MR
    Behav Brain Res; 2016 Sep; 311():183-191. PubMed ID: 27230394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.